Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2024-06-26

Clinical Trial Update: Study of the C5a/C5aR1 Axis in IgG4-associated Disease: a Potential Therapeutic Target [NA]

View source ↗

Summary

Clinical trial investigating the C5a/C5aR1 axis as a potential treatment for IgG4-related disease; currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Immunoglobulin G4-Related Disease | NA | Status: NOT_YET_RECRUITING